Institutional investors purchased a net $6.4 million shares of GERN during the quarter ended September 2013 and now own 40.91% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RIDGEBACK CAPITAL MANAGEMENT LLC Bought 7.5 Million shares of Geron Corp
S.A.C. CAPITAL ADVISORS LP Bought 700.0 Thousand shares of Geron Corp
BLACKROCK ADVISORS LLC Bought 338.7 Thousand shares of Geron Corp